Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_assertion type Assertion NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_head.
- NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_assertion wasGeneratedBy ECO_0000203 NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_provenance.
- NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_assertion wasDerivedFrom befree-2016 NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_provenance.
- NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_assertion SIO_000772 15621812 NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_provenance.
- NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_assertion evidence source_evidence_literature NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_provenance.
- NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_assertion description "[Imatinib, the ABL kinase inhibitor, is used not only for Philadelphia chromosome-positive (Ph + ) chronic myelogenous leukemia, but also for Ph + acute lymphoblastic leukemia (ALL), although resistance to the drug tends to develop in an early stage of the clinical course.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP474291.RAS7WyXDeB1ZH8HUGWhiH7lnR7WtkuzA7iYhOhOfqxrYI130_provenance.